RxDoctor Payments Data

Nicole Radabaugh

Family · Camden On Gauley, WVNPI 1003203316

Payments from drug & device makers

$2,246in general payments, 2019–2025

Across 135 payments — averaging $16.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$653
  • Alkermes, Inc.$324
  • AstraZeneca$297
  • Otsuka America Pharmaceutical, Inc.$241
  • Pfizer$176
  • Lilly USA, LLC$102
  • plus $454 from 10 others

What the payments were for

  • Food & beverage$2,246100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,246 in reported general payments places this provider in the 80th percentile of 1,507 family providers in West Virginia.

See all family providers in West Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide83$105,201
FarxigaDapagliflozin Propanediol59$52,869
Nurtec OdtRimegepant Sulfate20$28,096
MounjaroTirzepatide20$23,097
JardianceEmpagliflozin13$21,974
EliquisApixaban23$20,294
VraylarCariprazine Hcl11$16,252
OzempicSemaglutide16$14,820
Breo ElliptaFluticasone/Vilanterol24$11,842
Tresiba Flextouch U-100Insulin Degludec14$7,804
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$7,024
VascepaIcosapent Ethyl12$5,129
LantusInsulin Glargine,hum.Rec.Anlog27$4,106
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$3,654
Novolog FlexpenInsulin Aspart18$2,660

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$102$128,298103 claims
AstraZenecaFarxiga, Breztri Aerosphere$297$59,89370 claims
PfizerNurtec Odt, Eliquis$176$48,39043 claims
AbbVieVraylar$653$16,25211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,507 family providers in West Virginia.

Other family in Camden On Gauley

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →